October 12, 2022
Yuqian Liu, Pharm.D., and Michelle Booth, Pharm.D., of Magellan Rx Management, discuss the background and consequences of step therapy in Medicare Part B in an interview prior to their session at the AMCP Nexus 2022 meeting in National Harbor, Maryland.
October 12, 2022
The former Baltimore city health commissioner has been criticized for some of her views on COVID-19 mandates. In her talk opening the AMCP Nexus 2022 meeting, Wen said that if public health officials don’t take into account public attitudes, it could affect the ability to deal with future public health emergencies.
October 12, 2022
Kevin Astle, Pharm.D., discussed on-demand HIV preexposure prophylaxis (PrEP), the advent of long-term injectables, and updated CDC guidelines at the AMCP Nexus 2022 meeting in National Harbor, Maryland.
October 11, 2022
The former Baltimore city health commissioner’s positions on COVID-19 and other issues drawn some strong criticism. Former FDA Commissioner Scott Gottlieb is among those that have come to her defense.
October 22, 2021
Disparities, biosimilars and digital therapeutics were among the featured topics at the meeting in Denver that had 1,900 attendees.
October 21, 2021
Brenden O'Hara, clinical pharmacist of Blue Cross Blue Shield of North Carolina, discusses innovations in diabetes management and what’s to come in 2022 at AMCP Nexus 2021.
October 21, 2021
Juday, director of specialty product development at CVS Health, shares how CBT’s for insomnia can save payers and can yield cost savings with or without a digital component.
October 21, 2021
Consultant Jeffrey Casberg says biosimilars are coming on strong and that interchangeability may not be much for the products dispensed through specialty pharmacies because specialty pharmacies are often in frequent touch with physicians.
October 21, 2021
Page and Taddei-Allen of WellDyne discuss precision medicine and its implications for pharmacy management at this year's AMCP Nexus Conference
October 21, 2021
Melissa Andel, principal of CommonHealth Solutions, discusses Medicare Part D in the future — more particularly in the next year — and why these changes are being made during this year's AMCP Nexus conference.